Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print November 28, 2007, DOI:10.2164/jandrol.107.003848
Journal of Andrology, Vol. 29, No. 2, March/April 2008
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.107.003848

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/2/172    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenic, I.
Right arrow Articles by Steger, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenic, I.
Right arrow Articles by Steger, K.

In Vivo Application of Histone Deacetylase Inhibitor Trichostatin-A Impairs Murine Male Meiosis

IRINA FENIC*,#, HAMID M. HOSSAIN{dagger},#, VIOLETTA SONNACK*, SVETLIN TCHATALBACHEV{dagger}, FELIX THIERER{dagger}, JOHANNES TRAPP{ddagger}, KLAUS FAILING§, KAI S. EDLER||, MARTIN BERGMANN, MANFRED JUNG{ddagger}, TRINAD CHAKRABORTY{dagger} AND KLAUS STEGER*

From the * Department of Urology and Pediatric Urology and the {dagger} Institute of Medical Microbiology University of Giessen, Germany; the {ddagger} Institute of Pharmaceutical Sciences University of Freiburg, Germany; and the § Institute of Veterinary Physiology, Department of Biomathematics, the || Department of Forensic Medicine, and the Institute of Veterinary Anatomy, Histology, and Embryology, University of Giessen, Germany.

Correspondence to: Prof Dr Klaus Steger, Klinik und Poliklinik für Urologie und Kinderurologie, Rudolf-Buchheim-Strasse 7, 35385 Giessen, Germany (e-mail: Klaus.Steger{at}chiru.med.uni-giessen.de).


In vivo application of histone deacetylase (HDAC) inhibitor trichostatin-A (TSA) in mice results in male infertility. To get more insight into the mechanisms underlying this phenomenon, we performed a genome-wide expression analysis and investigated HDAC activity and degree of histone H3 and H4 acetylation in murine testes after TSA treatment. A significant decrease in HDAC activity and a weak increase in histone acetylation could be demonstrated at 2.5, 5.0, and 7.5 hours after TSA application. Gene expression analysis revealed 507 significantly regulated genes. Transcripts expressed in the somatic cells of the testis (Sertoli, Leydig, peritubular cells, and testis macrophages) or extratubular matrix were regulated as early as 2.5 hours after TSA application, whereas very few meiosis-specific genes were modulated after TSA treatment. In addition, members of the p53-noxa-caspase-3 proapoptotic pathway were regulated early. Applying in-situ hybridization, caspase-3-mRNA was found only in apoptotic spermatocytes, whereas TRP53/p53- and PMAIP1/noxa-mRNA could be demonstrated in spermatogonia and spermatocytes. Our data suggest that TSA impaired male meiosis, possibly through an indirect mechanism implicating somatic cells of the testis.

     Key words: Apoptosis, histone-deacetylase, mouse, spermatogenesis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society of Andrology.